Cultured mammary epithelial monolayers (BME-UV) express functional organic anion and cation transporters.

There is ongoing concern about the potential adverse effects of xenobiotic residues in cows' milk to the human consumer. Although drugs that are intentionally administered to lactating dairy cattle are rigorously regulated to prevent harmful residues, there are numerous other potential sources of exposure that are not as easily controlled. For example, cattle may be exposed to mycotoxins, pesticides and/or persistent organic pollutants through feed, water and inhalation of polluted air. Accurate estimates of the rate and extent of excretion of these compounds into milk is important to assess the risk of exposure through cows' milk. In the present study, the expression of carrier mediated transport processes in cultured monolayers of an immortalized bovine mammary epithelial cell line (BME-UV) was determined using a flow-through diffusion cell system, selective substrates and inhibitors of organic cation transporters (OCT) and organic anion transporters (OAT). The basal-to-apical (BL-to-Ap) flux of tetraethylammonium and estrone sulfate significantly exceeded their flux in the opposite direction. The addition of selective inhibitors to the donor compartment significantly decreased the BL-to-Ap flux of either selective substrate. These results suggest that both OCT and OAT are functionally expressed by BME-UV cells.

[1]  G. Wilson Cell culture techniques for the study of drug transport , 1990, European Journal of Drug Metabolism and Pharmacokinetics.

[2]  D. Swarup,et al.  Milk trace elements in lactating cows environmentally exposed to higher level of lead and cadmium around different industrial units. , 2008, The Science of the total environment.

[3]  A. M. Kaukonen,et al.  Transport evaluation of salicylic acid and structurally related compounds across Caco-2 cell monolayers and artificial PAMPA membranes. , 2008, European journal of pharmaceutics and biopharmaceutics.

[4]  L. Matherly,et al.  Role of rat organic anion transporter 3 (Oat3) in the renal basolateral transport of glutathione. , 2007, Chemico-biological interactions.

[5]  Xiaobin Han,et al.  Glucocorticoids stimulate ENaC upregulation in bovine mammary epithelium. , 2007, American journal of physiology. Cell physiology.

[6]  B. Schultz,et al.  Apical electrolyte concentration modulates barrier function and tight junction protein localization in bovine mammary epithelium. , 2007, American journal of physiology. Cell physiology.

[7]  R. Gehring,et al.  An overview of factors affecting the disposition of intramammary preparations used to treat bovine mastitis. , 2006, Journal of veterinary pharmacology and therapeutics.

[8]  H. Okamoto,et al.  Development of a human mammary epithelial cell culture model for evaluation of drug transfer into milk , 2006, Archives of pharmacal research.

[9]  J. Riviere,et al.  Application of risk assessment and management principles to the extralabel use of drugs in food-producing animals. , 2006, Journal of veterinary pharmacology and therapeutics.

[10]  Y. Sugiyama,et al.  Apical/Basolateral Surface Expression of Drug Transporters and its Role in Vectorial Drug Transport , 2005, Pharmaceutical Research.

[11]  Ismael Zamora,et al.  pH-Dependent passive and active transport of acidic drugs across Caco-2 cell monolayers. , 2005, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[12]  Akira Tsuji,et al.  Transporter-mediated drug delivery: recent progress and experimental approaches. , 2004, Drug discovery today.

[13]  M. Neville,et al.  Tight Junction Regulation in the Mammary Gland , 1998, Journal of Mammary Gland Biology and Neoplasia.

[14]  E. Schömig,et al.  1,1′-Diethyl-2,2′-cyanine (decynium22) potently inhibits the renal transport of organic cations , 1993, Naunyn-Schmiedeberg's Archives of Pharmacology.

[15]  S. Wright,et al.  The molecular and cellular physiology of basolateral organic anion transport in mammalian renal tubules. , 2003, Biochimica et biophysica acta.

[16]  L. Gallego,et al.  Residue persistence in sheep milk following antibiotic therapy. , 2003, Veterinary journal.

[17]  H. Koepsell,et al.  The Cation Transporters rOCT1 and rOCT2 Interact with Bicarbonate but Play Only a Minor Role for Amantadine Uptake into Rat Renal Proximal Tubules , 2002, Journal of Pharmacology and Experimental Therapeutics.

[18]  P. McNamara,et al.  Transporter Gene Expression in Lactating and Nonlactating Human Mammary Epithelial Cells Using Real-Time Reverse Transcription-Polymerase Chain Reaction , 2002, Journal of Pharmacology and Experimental Therapeutics.

[19]  Claus-Michael Lehr,et al.  Cell culture models of biological barriers : in vitro test systems for drug absorption and delivery , 2002 .

[20]  R. Carlin,et al.  Neurotransmitter-stimulated ion transport across cultured bovine mammary epithelial cell monolayers. , 2001, Journal of dairy science.

[21]  H. Endou,et al.  Characterization of organic anion transport inhibitors using cells stably expressing human organic anion transporters. , 2001, European journal of pharmacology.

[22]  M. Peaker,et al.  Transport of milk constituents by the mammary gland. , 2000, Physiological reviews.

[23]  M. Kataoka,et al.  Optimized conditions for prediction of intestinal drug permeability using Caco-2 cells. , 2000, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[24]  B. Heinrich-Hirsch,et al.  Exposition to and health effects of residues in human milk. , 2000, Advances in experimental medicine and biology.

[25]  D. Sitar,et al.  Tetraethylammonium and amantadine identify distinct organic cation transporters in rat renal cortical proximal and distal tubules. , 1999, The Journal of pharmacology and experimental therapeutics.

[26]  H. Kusuhara,et al.  Molecular Cloning and Characterization of a New Multispecific Organic Anion Transporter from Rat Brain* , 1999, The Journal of Biological Chemistry.

[27]  P. Markaki,et al.  Occurrence of aflatoxin M1 in commercial pasteurized milk determined with ELISA and HPLC. , 1997, Food additives and contaminants.

[28]  M. Neville,et al.  Active transport of nitrofurantoin across a mouse mammary epithelial monolayer. , 1997, The Journal of pharmacology and experimental therapeutics.

[29]  M. Neville,et al.  Active transport of nitrofurantoin across the mammary epithelium in vivo. , 1997, The Journal of pharmacology and experimental therapeutics.

[30]  P. McNamara,et al.  Active transport of cimetidine and ranitidine into the milk of Sprague Dawley rats. , 1996, The Journal of pharmacology and experimental therapeutics.

[31]  P. Artursson,et al.  Studying transport in absorptive epithelia , 1996 .

[32]  R. Bronaugh Methods for in Vitro Percutaneous Absorption , 1995 .

[33]  J. Westin Carcinogens in Israeli Milk: A Study in Regulatory Failure , 1993, International journal of health services : planning, administration, evaluation.

[34]  S. Duffull,et al.  Prospective evaluation of a model for the prediction of milk:plasma drug concentrations from physicochemical characteristics. , 1992, British journal of clinical pharmacology.

[35]  E. Begg,et al.  Prediction of Drug Distribution into Human Milk from Physicochemical Characteristics , 1990, Clinical pharmacokinetics.

[36]  M. Emery,et al.  Unexpected accumulation of acyclovir in breast milk with estimation of infant exposure. , 1987, Obstetrics and gynecology.

[37]  L. L. Rusoff Milk: its nutritional value at a low cost for people of all ages. , 1970, Journal of dairy science.

[38]  F. Rasmussen Active Mammary Excretion of N4-Acetylated Sulphanilamide , 1969, Acta Veterinaria Scandinavica.

[39]  F. Rasmussen Active Mammary Excretion of N4-Acetylated p-Aminohippuric Acid*) , 1969, Acta Veterinaria Scandinavica.